PULSE BIOSCIENCES, INC. — Director's Dealing 2023

Jul 7, 2023

SEC Form 4/A — Form 4/A

Issuer: Pulse Biosciences, Inc. (PLSE)
CIK: 0001625101
Period of Report: 2023-06-09

Reporting Person: Zanganeh Mahkam (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-06-09	Common Stock	X	86668	$2.05	Acquired	528836	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-06-09	Warrant (right to buy)	$2.05	X	86668	Disposed	2027-06-09	Common Stock (86668)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	27000	Indirect
Common Stock	14000	Indirect
Common Stock	107074	Indirect

Footnotes

F1: The number of shares beneficially owned, as reported on the Form 4 filed on June 13, 2023, erroneously included options held by the Reporting Person.